Leah Gerber Davis
Duke University
H-index: 30
North America-United States
Top articles of Leah Gerber Davis
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
PS14 Bimekizumab response up to 3 years in patients with moderate-to-severe plaque psoriasis who responded at week 16: post hoc results from the BE BRIGHT open-label extension … | British Journal of Dermatology | Richard B Warren Bruce Strober Mark Lebwohl Peter Foley Richard G Langley | 2023/6 |
34321 Bimekizumab efficacy and safety through 96 weeks in patients with moderate to severe plaque psoriasis: Results from the open-label extension period of the BE RADIANT … | Journal of the American Academy of Dermatology | Bruce Strober Carle Paul Andrew Blauvelt Diamant Thaçi Boni Elewski | 2022/9/1 |
34320 Bimekizumab efficacy in subgroups defined by prior systemic treatment in patients with moderate to severe plaque psoriasis | Journal of the American Academy of Dermatology | David Rosmarin Mark Lebwohl Steven R Feldman Petra Staubach-Renz Leah Davis | 2022/9/1 |
Bimekizumab efficacy through one year in patients with moderate to severe plaque psoriasis in subgroups defined by prior biologic treatment: Pooled results from four phase 3/3b … | SKIN The Journal of Cutaneous Medicine | Mark Lebwohl April W Armstrong Joseph F Merola Alice B Gottlieb Leah Davis | 2022/11/16 |
Bimekizumab versus secukinumab continuous maintenance of response at every visit through one year in patients with moderate to severe plaque psoriasis: Post-hoc results from … | SKIN The Journal of Cutaneous Medicine | Richard B Warren Curdin Conrad Peter Foley Lars Iversen Richard G Langley | 2022/11/16 |
32937 Bimekizumab treatment response is maintained up to 3 years in patients with psoriatic arthritis: Responder analyses from BE ACTIVE, a phase 2b dose-ranging study, and its … | Journal of the American Academy of Dermatology | Joseph F Merola Akihiko Asahina Christopher T Ritchlin Barbara Ink Deepak Assudani | 2022/9/1 |
33313 Bullous and subcutaneous Sweet syndrome with extracutaneous manifestations: A case report and review of the literature | Journal of the American Academy of Dermatology | Zisansha Zahirsha Lauren E Watchmaker Jodi Speiser Mariam Mafee | 2022/9/1 |
Mean percent PASI improvement with bimekizumab in patients with moderate to severe plaque psoriasis: Pooled results from four phase 3/3b trials | SKIN The Journal of Cutaneous Medicine | Andrew Blauvelt George Han Steve Tyring Jennifer Soung Tae Oh | 2021/11/5 |
Bone scan positivity in non-metastatic, castrate-resistant prostate cancer: external validation study | International braz j urol | Ashley W Johnston Thomas A Longo Leah Gerber Davis Daniel Zapata Stephen J Freedland | 2020/2 |
